Terms: = Testicular cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292
7 results:
1. Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of bmpr1a.
Lieberman S; Beeri R; Walsh T; Schechter M; Keret D; Half E; Gulsuner S; Tomer A; Jacob H; Cohen S; Basel-Salmon L; Mansur M; Berger R; Katz LH; Golomb E; Peretz T; Levy Z; Kedar I; King MC; Levy-Lahad E; Goldberg Y
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00054. PubMed ID: 31259752
[TBL] [Abstract] [Full Text] [Related]
2. Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
Bezan A; Posch F; Ploner F; Bauernhofer T; Pichler M; Szkandera J; Hutterer GC; Pummer K; Gary T; Samonigg H; Beyer J; Winder T; Hermanns T; Fankhauser CD; Gerger A; Stotz M
PLoS One; 2017; 12(4):e0176283. PubMed ID: 28430804
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
[TBL] [Abstract] [Full Text] [Related]
4. Expression of prostate-specific membrane antigen in normal and malignant human tissues.
Kinoshita Y; Kuratsukuri K; Landas S; Imaida K; Rovito PM; Wang CY; Haas GP
World J Surg; 2006 Apr; 30(4):628-36. PubMed ID: 16555021
[TBL] [Abstract] [Full Text] [Related]
5. Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.
Donahoe PK; Clarke T; Teixeira J; Maheswaran S; MacLaughlin DT
Mol Cell Endocrinol; 2003 Dec; 211(1-2):37-42. PubMed ID: 14656474
[TBL] [Abstract] [Full Text] [Related]
6. Does ND-YAG laser extend the indications for resection of pulmonary metastases?
Branscheid D; Krysa S; Wollkopf G; Bülzebruck H; Probst G; Horn M; Schirren J; Vogt-Moykopf I
Eur J Cardiothorac Surg; 1992; 6(11):590-6; discussion 597. PubMed ID: 1280452
[TBL] [Abstract] [Full Text] [Related]
7. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukaemia in Norway. Report on a national treatment program.
Moe PJ; Seip M; Finne PH
Haematologia (Budap); 1981; 14(3):257-63. PubMed ID: 6948760
[TBL] [Abstract] [Full Text] [Related]
